These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4047673)

  • 21. Chemotherapy for head and neck cancer.
    Tannock IF
    J Otolaryngol; 1984 Apr; 13(2):99-104. PubMed ID: 6202878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
    Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
    Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment for recurrent head and neck carcinomas].
    Tsukuda M
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):303-8. PubMed ID: 9492820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of neoadjuvant chemotherapy for management of resectable head and neck cancer].
    Horiuchi M; Tamura Y; Miyake H
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):417-24. PubMed ID: 8129381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
    Adelstein DJ; Saxton JP; Rybicki LA; Esclamado RM; Wood BG; Strome M; Lavertu P; Lorenz RR; Carroll MA
    J Clin Oncol; 2006 Mar; 24(7):1064-71. PubMed ID: 16505425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
    J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
    Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy.
    Doweck I; Denys D; Robbins KT
    Laryngoscope; 2002 Oct; 112(10):1742-9. PubMed ID: 12368607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.
    Khuri FR; Nemunaitis J; Ganly I; Arseneau J; Tannock IF; Romel L; Gore M; Ironside J; MacDougall RH; Heise C; Randlev B; Gillenwater AM; Bruso P; Kaye SB; Hong WK; Kirn DH
    Nat Med; 2000 Aug; 6(8):879-85. PubMed ID: 10932224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indications for cytostatic therapy of recurrent cancer].
    Schröder M; Stennert E; von Heyden HW; Scherpe A
    HNO; 1984 Jun; 32(6):245-8. PubMed ID: 6206035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cisplatin-5 fluorouracil in cervicofacial cancer recurrence].
    VaLlicioni J; Demard F; Santini J; Schneider M; Chauvel P
    Rev Laryngol Otol Rhinol (Bord); 1988; 109(1):9-11. PubMed ID: 3375632
    [No Abstract]   [Full Text] [Related]  

  • 37. [Head and neck: intra-arterial chemotherapy and combined radiotherapy].
    Homma A
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1027-30. PubMed ID: 17682302
    [No Abstract]   [Full Text] [Related]  

  • 38. [Intra-arterial chemotherapy as the initial treatment in advanced tumors of the head and neck].
    Lunghi F
    Acta Otorhinolaryngol Ital; 1986; 6(2):119-25. PubMed ID: 2428201
    [No Abstract]   [Full Text] [Related]  

  • 39. [Long-term studies after intra-arterial cytostatic therapy of head and neck tumors].
    Szabó G; Kovács A; Gyenes V; Suba Z
    Orv Hetil; 1989 Apr; 130(16):823-6. PubMed ID: 2471128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An evaluation of multi-disciplinary treatment combined with intra-arterial chemotherapy of head and neck cancer].
    Matsuura S; Makino S; Satake B; Shimizu R; Sakaino K; Maehara Y; Nakamura Y; Miyama J
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1057-62. PubMed ID: 3932709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.